Abstract

Adverse drug reactions have become a major cause of morbidity to all patients. This is no wonder, since the number of medications approved by the United States Food and Drug Administration (FDA) has risen exponentially over the years. With the increasing pressure of pharmaceutical companies to have their product approved by the FDA because of cost constraints and other factors, and with the increasing pressure of the FDA to get new, novel, and potentially beneficial drug treatments to consumers, some new drugs can potentially have an adverse effect profile that is somewhat incomplete and may not be readily known until the drug is on the market for some period of time or until postmarketing surveillance on the product is completed. Rather than focus on all adverse drug effects, this discussion will focus only on one type: drug-induced sexual dysfunction.